MedPath

TRIANAL CAPSULES

TRIANAL CAPSULES

Dormant
DIN Number

01971417

Drug Class

Human

Market Date

Jun 2, 1997

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01971417
AIG Number0301241001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
N02BA71 ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (3)

ACETYLSALICYLIC ACIDActive
Strength: 330 MG
Monograph: ACETYLSALICYLIC ACID
BUTALBITALActive
Strength: 50 MG
Monograph: BUTALBITAL
CAFFEINEActive
Strength: 40 MG
Monograph: CAFFEINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.